Indivior (LON:INDV) Shares Down 15.7% – Should You Sell?

Indivior PLC (LON:INDV) shares traded down 15.7% during mid-day trading on Thursday . The company traded as low as GBX 548.71 ($6.90) and last traded at GBX 732 ($9.21). 1,888,371 shares were traded during mid-day trading, an increase of 166% from the average session volume of 709,477 shares. The stock had previously closed at GBX 868 ($10.92).

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 1,800 ($22.65) price target on shares of Indivior in a report on Tuesday, December 17th.

Indivior Price Performance

The firm has a market capitalization of £1.14 billion, a price-to-earnings ratio of -606.93, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a fifty day moving average price of GBX 928.06 and a two-hundred day moving average price of GBX 853.71. The company has a quick ratio of 1.52, a current ratio of 0.83 and a debt-to-equity ratio of -170.06.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.